Search results
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
FOX 4 Kansas City· 7 days agoGordian Biotechnology, an in vivo drug discovery and development company, today announced its...
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
The Record Gazette· 7 days agoGordian Biotechnology Scientists Process Tissue From a Mosaic Screening in the Company’s South San Francisco Headquarters
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 13 hours agoNovartis said it’s paying $1 billion upfront and up to $750 million more in milestone payments for...
Amgen first-quarter profit dips 1%, revenue rises 22%
Reuters via Yahoo Finance· 5 hours agoThe biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. Revenue rose ...
Maia Biotechnology director buys $39,919 in company shares By Investing.com
Investing.com· 6 days agoMAIA Biotechnology, Inc. (NYSE:MAIA) director Louie Ngar Yee acquired a significant number of...
Valmark Advisers Inc. Makes New $225,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 3 days agoValmark Advisers Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Zacks· 20 hours agoFree Report) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.17. This quarterly report represents an earnings surprise of 82.35%. A quarter ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 7 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids...
Digital Journal· 10 hours agoPRESS RELEASE Published May 2, 2024 Newsfile Carlsbad, California--(Newsfile Corp. - May 2, 2024) - CB Therapeutics , a leading biotechnology firm specializing in precision ...
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
Reuters via Yahoo Finance· 4 hours agoThe biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results ...
